IRIS
MUSIANI, Piero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.746
EU - Europa 6.187
AS - Asia 3.413
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 10
SA - Sud America 4
AF - Africa 2
Totale 16.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.683
UA - Ucraina 1.444
CN - Cina 1.383
IE - Irlanda 1.030
TR - Turchia 1.026
GB - Regno Unito 984
SE - Svezia 757
SG - Singapore 722
FR - Francia 650
DE - Germania 457
IT - Italia 335
FI - Finlandia 273
IN - India 223
RU - Federazione Russa 161
CA - Canada 53
CZ - Repubblica Ceca 30
BE - Belgio 28
VN - Vietnam 28
EU - Europa 19
GR - Grecia 18
IL - Israele 14
MX - Messico 8
AU - Australia 6
HK - Hong Kong 6
IR - Iran 6
ES - Italia 5
LT - Lituania 4
NZ - Nuova Zelanda 4
PK - Pakistan 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
JP - Giappone 1
NL - Olanda 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 16.381
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.443
Chandler 1.249
Dublin 1.025
Southend 818
Singapore 594
Izmir 522
Princeton 492
Dearborn 421
Nanjing 421
Wilmington 346
Cambridge 257
Beijing 218
Ann Arbor 180
Ashburn 157
Nanchang 142
Boardman 139
Woodbridge 130
New York 116
Santa Clara 114
Grevenbroich 99
Altamura 94
Shenyang 71
Hebei 67
Tianjin 62
Houston 61
Chieti 58
Jiaxing 55
Kunming 51
Jinan 42
Norwalk 41
Hangzhou 39
Orange 39
Changsha 37
San Mateo 35
Augusta 32
Helsinki 31
Brno 30
Toronto 27
Brussels 26
Dong Ket 26
Hefei 25
Grafing 24
Guangzhou 22
Los Angeles 22
Romola 19
Washington 19
Andover 18
Ningbo 18
Auburn Hills 17
Chicago 17
Leawood 17
Ottawa 17
London 16
Milan 16
Lanzhou 13
Changchun 11
Taizhou 11
Zhengzhou 11
Falls Church 10
Düsseldorf 9
Rome 9
Mexico City 8
Seattle 8
Simi Valley 8
Lanciano 7
Munich 6
Vasto 6
Walnut 6
Frankfurt am Main 5
Fuzhou 5
Haikou 5
Sydney 5
Tappahannock 5
Baotou 4
Ferrara 4
Hong Kong 4
Ardabil 3
Chongqing 3
Istanbul 3
Jülich 3
Kocaeli 3
Monmouth Junction 3
Mumbai 3
Redwood City 3
San Donà di Piave 3
Shanghai 3
Shaoxing 3
Trumbull 3
Arcene 2
Auckland 2
Bangalore 2
Bari 2
Cedar Knolls 2
Curtarolo 2
Desio 2
Harbin 2
Layyah 2
Montesilvano Marina 2
Pescara 2
Porto San Giorgio 2
Totale 10.294
Salva come PNG Salva come JPEG
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 203
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 182
Role of GM-CSF in cryptogenic organizing pneumonia 134
Ruolo della IL-1 nella regolazione della produzione del TGFbeta1 e della IL-8 nei tumori del polmone "non-small cell". 125
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 121
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 110
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. 107
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 104
Transforming growth factor beta1, interleukin-8 and interleukin-1 in human non-small cell lung tumor cell lines and primary tumors. 103
TGF-beta-1 and IL-8 in human long cancer cell lines and primary tumors: constitutive production and modulation by IL-1 102
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 99
T3 expression by human thymocytes in culture. 97
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 95
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 95
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 94
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 94
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 93
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 92
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 92
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 91
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 91
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 89
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 89
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 88
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 88
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 88
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 87
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 87
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 87
Carcinomi polmonari umani: produzione di TGFbeta1 86
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 86
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 86
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 85
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 84
Analysis of IL-2-receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer. 83
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 83
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 83
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 83
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 83
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 83
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 82
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 82
Proliferative capabilities of T3-positive thymocytes. 82
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 82
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 82
IL-10 potentiates the effect of dexamethasone in inhibiting the proliferation of resting, activated and "corticoresistant" human T cells 82
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 81
Polymorphonuclear Leukocyte Apoptosis is Inhibited by Platelet-released mediators, Role of TGFbeta-1 81
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 81
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 81
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 81
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 80
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 79
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 78
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 78
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 77
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 77
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 77
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. 77
Neutrophils in anti-cancer immunological strategies: old players in new games 77
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 77
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 77
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 76
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 76
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 76
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 76
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 76
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 76
Echinococcus granulosus: specific quantification of the two most immunoreactive antigens in hydatid fluids. 76
Inactivation of the IL-6 gene prevents development of multricentric Castleman's disease in C/EBP beta-deficient mice 75
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 75
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 75
Alpha-l-antitrypsin deficiency and human pathology. 75
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 75
5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory 74
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 74
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 74
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. 74
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 74
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 74
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 74
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 73
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 73
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 73
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. 73
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 73
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 72
THE ROLE OF ARACHIDONIC ACID METABOLITE PGE2 ON T CELL PROLIFERATIVE RESPONSE. 72
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 72
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 72
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 72
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. 72
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 72
Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells. 72
Immunological prevention of a multigene cancer syndrome. 71
Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation 71
Neutrophils in the antitumoral immune response 71
Echinococcus granulosus: preparation of monosepcific antisera against antigens in sheep hydatid fluid. 71
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. 70
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 70
Totale 8.493
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.572 0 0 0 0 0 323 416 351 34 123 298 27
2020/20211.618 261 5 246 9 221 340 10 6 135 253 44 88
2021/2022926 18 12 7 122 142 32 33 82 65 30 121 262
2022/20233.423 294 297 164 446 376 773 204 260 446 38 72 53
2023/20241.387 136 49 65 36 104 428 363 40 11 20 14 121
2024/20251.262 224 489 401 75 63 10 0 0 0 0 0 0
Totale 16.687